The Scientist

» NCATS

Most Recent

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: Mining Existing Drugs for Ebola Treatments

Mining Existing Drugs for Ebola Treatments

By | December 17, 2014

Researchers hope to repurpose already-approved drugs into potential anti-Ebola therapies.

0 Comments

image: NIH to Resurrect Old Drugs

NIH to Resurrect Old Drugs

By | June 20, 2013

Academic scientists and the pharmaceutical industry will collaborate on a new program to speed up the drug development process.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech